First characterized in microbial systems and neurodegenerative diseases, ClpP is implicated in hepatic disorders such as non-alcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC), and liver metastases. Here, CLPP is linked to metabolic dysfunction-associated steatohepatitis.